Join to View Full Profile
3213 W. Wheeler St.#405Seattle, WA 98199
Phone+1 206-898-4515
Dr. West is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Howard (Jack) West, MD, is a thoracic oncologist with over two decades of clinical experience. He led the medical therapeutics component of the thoracic oncology program at the Swedish Cancer Institute in Seattle, WA from 2003-2016. At that time, he moved to City of Hope Comprehensive Cancer Center in the Los Angeles area, where he was Vice President of AccessHope, a novel service providing remote expert cancer consultation services to patients around the US, in addition to serving as a thoracic oncology subspecialist in the clinic and doing telemedicine visits at City of Hope.
In the fall of 2023, Dr. West joined Summit Therapeutics as Vice President of Clinical Development, focused on research and strategy around ivonescimab, a novel bispecific antibody targeting PD-1 and VEGF in lung and other cancer types.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1998 - 2002
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1998- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
Harvard Medical SchoolClass of 1996
University of CambridgeM Phil, Experimental Biology, 1990 - 1991
Certifications & Licensure
CA State Medical License 2012 - 2026
NV State Medical License 2022 - 2025
TX State Medical License 2012 - 2025
AK State Medical License 2022 - 2024
ID State Medical License 2022 - 2024
WA State Medical License 1998 - 2024
WY State Medical License 2022 - 2024
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2001 Dec 01
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01
- Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer.Arthi Sridhar, Howard Jack West, Eric K Singhi
Clinical Lung Cancer. 2024-11-01 - 2 citationsExamining crossover and postprotocol therapies in first-line immunotherapy trials in non-small cell lung cancer.Aakash Desai, Caleb J Smith, Joshua C Pritchett, Konstantinos Leventakos, Howard Jack West
Cancer. 2024-08-15 - 5 citationsCancer Care in the Era of Artificial Intelligence.Matthew Kurian, Jacob J Adashek, Howard Jack West
JAMA Oncology. 2024-05-01
External Links
- Global Resource for Advancing Cancer Researchhttp://cancerGRACE.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
